Obalon Therapeutics, Inc. Gains 114.95%
Mon, Dec 07, 2020 at 05:30 PM
Obalon Therapeutics, Inc. (OBLN:NASDAQ) rocketted at $2.3, a gain of 115%. The stock got featured on our News Catalysts scanner on Tue 10 Nov 20 at 08:33 AM in the 'EARNINGS' category. From Fri 20 Nov 20, the stock recorded 44.44% Up Days and 40.00% Green Days
The stock spiked on Wed 02 Dec 20 at $1.65 with a volume of 13M+.
About Obalon Therapeutics, Inc. (OBLN:NASDAQ)
Obalon Therapeutics Inc is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss.
Top 10 Gainers:
- Obalon Therapeutics, Inc. (OBLN:NASDAQ), 114.95%
- Eastman Kodak Company (KODK:NYSE), 59.89%
- Gamida Cell Ltd. (GMDA:NASDAQ), 56.24%
- Oncternal Therapeutics, Inc. (ONCT:NASDAQ), 49.62%
- Greenland Technologies Holding Corporation (GTEC:NASDAQ), 49.37%
- KBNT (KBNT:NASDAQ), 43.62%
- HPK (HPK:NASDAQ), 39.6%
- Fate Therapeutics, Inc. (FATE:NASDAQ), 37.8%
- Hennessy Capital Acquisition Corp. IV (HCAC:NASDAQ), 35.32%
- EHang Holdings Limited (EH:NASDAQ), 34.87%